SEC Form 4 · accession 0001209191-16-116950
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Scott Whitehurst
Officer — Chief Financial Officer
Period of report
May 2, 2016
Accepted (ET)
May 3, 2016 · 2:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $12.99 | May 2, 2016 | A | 300,000 | A | Aug 1, 2016 | May 1, 2026 | Common Stock | 300,000 | 300,000 | D |
Remarks
Such options will vest and become exercisable over a four-year period following May 2, 2016 (the "Grant Date"), with 6.25% vesting per quarter over the first year following the Grant Date and 25% vesting on each of the second, third and fourth anniversaries of the Grant Date.